Karur Vysya Bank announced a 1:5 bonus share issue, its first in seven years, alongside a 13.7% YoY rise in Q1 FY26 net profit to Rs 521.45 crore. Interest income rose 12% to Rs 2,569 crore. The record date for the bonus issue is August 26, 2025.

Motilal Oswal Financial Services on Thursday reported its highest-ever quarterly net profit of Rs 1,430 crore for the June quarter, marking a 40 per cent year-on-year jump, buoyed by robust performance across asset management, private wealth and capital markets businesses.

Zerodha faces a drop in demat market share despite rising AUM, prompting CEO Nithin Kamath to seek insights on evolving growth strategies beyond traditional customer acquisition methods.

Nestle India reported a 13.4% YoY drop in Q1 FY26 net profit to Rs 647 crore, citing high input and operational costs. Revenue rose 5.9% to Rs 5,096 crore. Despite profit pressure, the company saw growth in e-commerce, out-of-home business, and urban demand.

Capital Small Finance Bank posted a 7% rise in Q1 FY26 net profit to ₹32 crore, despite a nearly fourfold jump in provisions due to NBFC-MFI defaults. Operating profit rose 21%, and advances and deposits saw double-digit growth.

The S&P 500 and the Nasdaq opened higher on Thursday as investors assessed tech earnings and monitored trade negotiations, while losses in shares of IBM, Honeywell and UnitedHealth weighed on the Dow.

Alphabet shares rose more than 3% in early trading on Thursday as the Google parent s earnings underscored a key message to investors: AI spending is climbing, but so are the returns.

The European Central Bank held interest rates steady Thursday as policymakers waited to see whether the eurozone would be hit by higher US tariffs threatened by President Donald Trump.

Tesla s shares plummeted by 8% amid concerns over declining EV sales and delayed autonomous driving advancements. CEO Elon Musk s robotaxi rollout faces regulatory hurdles, particularly in California, despite promises of widespread U.S. availability. Investors express skepticism, citing sales declines and unmet promises, questioning Tesla s growth trajectory and lofty valuation.

Cipla s June quarter earnings are anticipated to reveal a mixed performance, with robust India sales partially offsetting challenges in the US generics market. Revenue is expected to increase, while EBITDA margins may decline due to lower US contributions. Investor attention will be directed towards the US business trajectory, pricing dynamics, and the resurgence of India s trade generics segment.